We take this opportunity to specifically thank the reviewers and editors for their kindattention to our paper. References 1. Haque A, Banik NL, Ray SK: Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma[J]. X-396 molecular weight Neurochem Res 2007,32(12):2203–2209.PubMedCrossRef 2. Che XM, Cui DM, Wang Y, Shi W, Liu TJ, Wang K: Isolation, Culture and Identification and Biological Character Research of Brain Tumor Stem Cells in Glioblastoma Multiforme in Vitro [J]. Chinese Journal of Clinical Neurosciences 2007,15(6):561–569. 3. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C,
Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors[J]. Cancer Res 2003,63(18):5821–5828.PubMed 4. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, Vitis SD, Fiocco
R, Foroni C, Dimeco F, Vescovi A: Isolation and characterization of tumorigenic, stem-like INCB024360 neural precursors from human glioblastoma[J]. Cancer Res 2004,64(19):7011–7021.PubMedCrossRef 5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells[J]. Nature 2004,432(7015):396–401.PubMedCrossRef 6. Kondo T, Setoguchi T, Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line[J]. Proc Natl Acad Sci USA 2004,101(3):781–786.PubMedCrossRef 7. Zang C, Wächter M, Liu H, Posch MG, Fenner MH, Stadelmann C, von Deimling A, Possinger K, Black KL, Koeffler HP, Elstner E: Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas[J]. PJ34 HCl J Neurooncol 2003,65(2):107–118.PubMedCrossRef 8. Kaba SE, Kyritsis AP, Conrad C, Gleason MJ, Newman R, Levin VA, Yung WK: The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin)[J]. J Neurooncol 1997,34(2):145–151.PubMedCrossRef
9. Phuphanich S, Scott C, Fischbach AJ, Langer C, Yung WK: All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study(RTOG 91–13) in patients with recurrent malignant astrocytoma[J]. J Neurooncol 1997,34(2):193–200.PubMedCrossRef 10. Engelhard HH, Duncan HA, Del Canto M: Molecular characterization of glioblastoma cell differentiation[J]. Neurosurgery 1997,41(4):886–896.PubMedCrossRef 11. Toda M, Miura M, Asou H, Toya S, Uyemura K: Cell growth suppression of astrocytoma C6 cells by glial fibrillary acidic protein cDNA transfection[J]. J Neurochem 1994,63(5):1975–1978.PubMedCrossRef 12. Kokunai T, Izawa I, Tamaki N: Overexpression of p21WAF1/CIP1 induces cell differentiation and growth inhibition in a human glioma cell line[J]. Int J Cancer 1998,75(4):643–648.PubMedCrossRef 13. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, Black KL, Yu JS: Isolation of cancer stem cells from adult glioblastoma multiforme[J].